Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 31, Issue 3, Pages 1193-1203
Publisher
FASEB
Online
2016-12-17
DOI
10.1096/fj.201600749r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
- (2016) David Viola et al. ENDOCRINE-RELATED CANCER
- Effects of receptor tyrosine kinase inhibitors on VEGF165a- and VEGF165b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
- (2015) Joanne J Carter et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypertension induced by chemotherapeutic and immunosuppresive agents: A new challenge
- (2015) Simon Abi Aad et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With SunitinibNovelty and Significance
- (2015) Stephanie Lankhorst et al. HYPERTENSION
- Cediranib Aims for a Comeback
- (2015) C. Schmidt JNCI-Journal of the National Cancer Institute
- Cediranib Aims for a Comeback
- (2015) C. Schmidt JNCI-Journal of the National Cancer Institute
- Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib
- (2014) Stephanie Lankhorst et al. HYPERTENSION
- Estimating the clinical risk of hypertension from VEGF signal inhibitors by a non-clinical approach using telemetered rats
- (2014) Takehito Isobe et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Cardiovascular responses to retigabine in conscious rats - under normotensive and hypertensive conditions
- (2013) L V Fretwell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
- (2012) Peter Kruzliak et al. ANGIOGENESIS
- Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors
- (2012) Francesca Musumeci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
- (2011) Ehud Grossman et al. AMERICAN JOURNAL OF MEDICINE
- Sunitinib, a Receptor Tyrosine Kinase Inhibitor, Increases Blood Pressure in Rats without Associated Changes in Cardiac Structure and Function
- (2011) E. Blasi et al. Cardiovascular Therapeutics
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats
- (2010) SM Gardiner et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors
- (2010) Emily S. Robinson et al. HYPERTENSION
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
- (2010) Mariëtte H.W. Kappers et al. HYPERTENSION
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer
- (2010) Rebecca L Stone et al. LANCET ONCOLOGY
- Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?
- (2010) C. Vaklavas et al. ONCOLOGIST
- Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
- (2009) Carie S. Facemire et al. HYPERTENSION
- Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects
- (2009) Mariëtte HW Kappers et al. JOURNAL OF HYPERTENSION
- Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors
- (2009) Kelly L. Snider et al. Targeted Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search